ENTRY       K15967                      KO
NAME        mtmW
DEFINITION  ketoreductase
PATHWAY     ko01057  Biosynthesis of type II polyketide products
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Metabolism
              Metabolism of terpenoids and polyketides
               01057 Biosynthesis of type II polyketide products
                K15967  mtmW; ketoreductase
DBLINKS     RN: R09354
            UniProt: Q194Q1
REFERENCE   PMID:16571899
  AUTHORS   Albertini V, Jain A, Vignati S, Napoli S, Rinaldi A, Kwee I, Nur-e-Alam M, Bergant J, Bertoni F, Carbone GM, Rohr J, Catapano CV
  TITLE     Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy.
  JOURNAL   Nucleic Acids Res 34:1721-34 (2006)
REFERENCE   PMID:12733914
  AUTHORS   Remsing LL, Gonzalez AM, Nur-e-Alam M, Fernandez-Lozano MJ, Brana AF, Rix U, Oliveira MA, Mendez C, Salas JA, Rohr J
  TITLE     Mithramycin SK, a novel antitumor drug with improved therapeutic index, mithramycin SA, and demycarosyl-mithramycin SK: three new products generated in the mithramycin producer Streptomyces argillaceus through combinatorial biosynthesis.
  JOURNAL   J Am Chem Soc 125:5745-53 (2003)
///
